Skip to content Skip to navigation

Multiple Myeloma Research Foundation Contributes to Genomic Data Commons

September 28, 2016
by David Raths
| Reprints
National Cancer Institute commons to include data on more than 30,000 patients by the end of 2016

The National Cancer Institute (NCI) announced Sept 28 that the Multiple Myeloma Research Foundation has become the first nonprofit organization to donate genomic and clinical data to NCI’s Genomic Data Commons (GDC).

The GDC is a core component of the Cancer Moonshot and the President’s Precision Medicine Initiative, and it benefits from $70 million allocated to NCI to lead efforts in cancer genomics as part of the initiative.

It is a publicly available database that promotes the sharing of genomic and clinical data among researchers and facilitates precision medicine in oncology. It will include data on more than 30,000 patients who have many types of cancers by the end of the year. Multiple myeloma is the second most common blood cancer, but large amounts of genomic data about this disease and other cancers have not been readily accessible to the research community.

At a Sept. 28 Boston meeting, the Health Care Forum: War on Cancer, Doug Lowy, M.D., NCI’s acting director, said, “Data sharing is essential to advancing cancer research, and I cannot overstate the value of the data that MMRF is providing — not only genomic data but also full clinical data as well. Combining genomic and clinical information will create an invaluable resource for all researchers worldwide studying this disease who are working toward new, more effective treatments.”

Louis Staudt, M.D., Ph.D., director of NCI's Center for Cancer Genomics, said, “The MMRF is a research and advocacy organization conducting clinical studies that incorporate whole-genome, whole-exome, and RNA sequencing into their study analyses, The GDC gains power with each new submission, and the contribution of MMRF data will enable the discovery of potentially actionable and life-changing insights into multiple myeloma and its response to therapy that could be used by cancer researchers, doctors, and patients.”

Launched earlier this year, the GDC allows researchers to submit genetic and clinical data, such as cancer imaging and histological data, and integrate these data with information on the molecular profiles of tumors as well as treatment responses. All patient information in the GDC has been de-identified, NCI said, meaning that personal information, such as addresses, Social Security numbers, and other possible identifiers, are not present — only crucial genetic data and key demographic information are available.

A key contribution to the GDC will be information from MMRF’s newest genomic study, Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile (CoMMpass). The trial has enrolled more than 1,150 patients to date and is currently the largest genomic and clinical study of this disease. African-Americans represent about 18 percent of the patients enrolled in CoMMpass, based on an interim analysis. The participation of African-Americans in this study is significant given that multiple myeloma occurs about twice as often in African-Americans than in whites.

Over the next eight years or longer, patients in CoMMpass will get a repeat biopsy and a new genomic analysis at each six-month checkup and/or at disease progression. Tumor samples are being collected and analyzed when possible at the time of any relapse. The genomic data from these analyses will be immediately deposited in the GDC, with an anticipated sample size of near 1,000 cases by the spring of 2017. New data will be deposited every six months at a minimum.

 

Topics

News

Two Republican Senators Unveil Proposed ACA Replacement Bill

Two Republican Senators, Bill Cassidy of Louisiana and Susan Collins of Maine, on Monday unveiled a proposed bill, called The Patient Freedom Act of 2017, that, rather than dismantling the Affordable Care Act (ACA), offered a partial replacement that would allow states to continue operating under the law if they choose.

Norris Cochran Tapped to Serve as Acting Secretary at HHS

Norris Cochran has been tapped to serve as Acting Secretary of the U.S. Department of Health and Human Services (HHS) following the departure of former HHS Secretary Sylvia Burwell as part of the ongoing Trump Administration transition.

Consumers Increasingly Willing to Try Telehealth, New Survey Finds

About one in five consumers said they would switch their current primary care provider (PCP) if another PCP in their area offered telehealth visits, according to American Well’s latest survey.

New York Presbyterian Brooklyn Methodist Revalidated as EMRAM Stage 7

Due to its use of RFID technology to improve patient care and outcomes, New York Presbyterian Brooklyn Methodist Hospital (NYPBMH) has received acute care Stage 7 revalidation on the HIMSS Analytics Electronic Medical Record Adoption Model (EMRAM).

Dana Alexander Named 2016 HIMSS Nursing Informatics Leadership Award Winner

Dana Alexander, R.N., has been named the recipient of the 2016 HIMSS-ANI Nursing Informatics Leadership Award, a joint award sponsored by Alliance for Nursing Informatics (ANI) and HIMSS.

Agency Leadership Update: Collins Stays at NIH, Bindman Leaves AHRQ

As President-elect Donald Trump is sworn in as the United States’ 45th president at noon today, there has been an ongoing administration shuffle as agency leaders have stepped down as part of the presidential transition.